NYSE:BAXMedical Equipment
Baxter International (BAX) Q4 EPS Loss Deepens And Tests Bullish Margin Recovery Narrative
Baxter International (BAX) opened 2026 coming off a tough finish to last year, with Q4 2025 revenue at US$2,974 million and a basic EPS loss of US$2.01, alongside a net loss from ongoing operations of US$1,035 million. Over recent quarters, revenue moved from US$2,699 million in Q3 2024 to US$2,625 million in Q1 2025 and then to US$2,974 million in Q4 2025. EPS swung between a modest profit of US$0.24 in Q2 2025 and losses in several periods, setting up a story where top line stability...